Shanghai Haixin Group Co (SHSE:600851) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600851 Shanghai Haixin Group Co Ltd SHSE:600851
48 GF Score
Price ¥7.77
GF Value ¥4.29
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Haixin Group Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:600851
48GF Score
Shanghai Haixin Group Co Ltd SHSE:600851
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Haixin Group Co (SHSE:600851) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haixin Group Co stock appears to be overvalued. The current stock price of ¥7.77 is trading 81.1% above its estimated GF Value™ of ¥4.29. GuruFocus considers Shanghai Haixin Group Co to be Significantly Overvalued.

Key valuation signals for SHSE:600851:

  • FFO:
  • GF Value™: ¥4.29 vs. price of ¥7.77 (81.1% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600851 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Haixin Group Co Business Description

Other Exchanges 900917:China
Address 688 Changxing Road, Dongjing Songjiang, Shanghai, CHN, 201619
Shanghai Haixin Group Co Ltd is a China-based company engaged in the pharmaceuticals business. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. Further, it is also involved in financial investment, industrial plant rental management, and textile products business. Geographically, the activities are carried out through China.
48GF Score

Get the complete analysis for SHSE:600851

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.77
Price
¥4.29
GF Value